EQS-News: Immunic, Inc : Immunic to Participate in Investor and Scientific Conferences in August finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.
/PRNewswire/ Immunic, Inc. (Nasdaq: IMUX), a biotechnology company developing a clinical pipeline of orally administered, small molecule therapies for.
Immunic to Participate in Industry and Scientific Conferences in July streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
Issuer: Immunic, Inc. / Key word(s): Conference Immunic to Participate in Industry and Scientific Conferences in July 28.06.2022 / 12:30 The issuer is solely responsible for the
Issuer: Immunic, Inc. / Key word(s): Conference Immunic to Participate in Industry and Scientific Conferences in July 28.06.2022 / 12:30 The issuer is solely responsible for the content of this announcement. Immunic to Participate in Industry and Scientific Conferences in July NEW YORK, June 28,.